companydata.dkAdaptVac ApS: Financial statements 2021
CVR: 38732730
AdaptVac ApS (CVR 38732730) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,330,522 and a net result of DKK -1,781,825 compared with DKK 15,460,206 the year before. That is a decrease of 93.4% compared with the year before. Equity amounted to DKK 12,556,754. The solvency ratio was 82.6%. The company had 5 employees in the financial year.
- Gross Profit
- 1,330,522 kr.
- Profit/Loss
- -1,781,825 kr.
- Equity
- 12,556,754 kr.
- Total Assets
- 15,193,534 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.3 mio. | -1.8 mio. | 12.6 mio. | 5 |
| 2020 | - | 20.2 mio. | 15.5 mio. | 15.3 mio. | 3 |
| 2019 | - | 1.4 mio. | -185 t. | -122 t. | 3 |
| 2018 | - | 432 t. | 334 t. | 64 t. | 0 |
Find more companies like AdaptVac ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
AdaptVac ApS has published its annual report for 2020. Gross profit came to DKK 20,231,326, and the net result was DKK 15,460,206.
As of May 27, 2021, Jacob Hjulmand has joined the board of directors of AdaptVac ApS.
As of May 27, 2021, Bent Ulrich Frandsen has left the board of directors of AdaptVac ApS.
As of February 1, 2021, EXPRES2ION BIOTECHNOLOGIES ApS is registered as an owner of AdaptVac ApS with an ownership share of 33%.
About AdaptVac ApS
AdaptVac ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Willem Adriaan De Jongh and Adam Frederik Sander Bertelsen. The company is owned by EXPRES2ION BIOTECHNOLOGIES ApS and NextGen Vaccines Holding ApS. In 2025, the company reported a gross profit of DKK -3,160,505 and a net result of DKK -7,053,665 compared with DKK 1,714,349 the year before. Equity amounted to DKK 10,808,696.